WCM
KYNB

Weld Capital Management’s Kyntra Bio KYNB Stock Holding History

Weld Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-317
Closed -$321K – 545
2020
Q2 		$321K Sell
317
-204
-39% -$189K 0.13% 262
2020
Q1 		$453K Buy
+521
New +$518K 0.23% 151
2019
Q3 		– Sell
-558
Closed -$630K – 837
2019
Q2 		$630K Buy
+558
New +$611K 0.12% 309

Other funds holding KYNB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Weld Capital Management's KYNB Position: Q3 2020 in Review

Weld Capital Management sold out of Kyntra Bio (KYNB) in Q3 2020, closing a stake of 317 shares — an estimated $321K sold.

Weld Capital Management first reported a position in KYNB in Q2 2019 and held it in 3 quarters. The position peaked at $630K in Q2 2019. 208 funds tracked by Wall St. Rank hold KYNB as of Q3 2020.

  • Weld Capital Management reported no remaining Kyntra Bio position as of Q3 2020 after selling out during the quarter.
  • Weld Capital Management sold 317 Kyntra Bio shares in Q3 2020, an estimated $321K.
  • Weld Capital Management first reported a position in Kyntra Bio in Q2 2019 and held it in 3 quarters.
  • Weld Capital Management's Kyntra Bio position peaked at $630K in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2020.

Based on Weld Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.